Reverse cardiac remodeling by SGLT2i in non-diabetic patients with HFrEF
Video navigation menu
- Design of the EMPA-TROPISM trial 5:36
- Results of the trial 8:46
This video was recorded in response to a recent publication in J Am Col Cardiol by Carlos Santos-Gallego and colleagues.
Carlos Santos-Gallego is a cardiologist at Icahn School of Medicine at Mount Sinai, New York, NY, USA
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.